Guardant Health
295 hedge funds and large institutions have $3.21B invested in Guardant Health in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 102 increasing their positions, 87 reducing their positions, and 51 closing their positions.
177% more call options, than puts
Call options by funds: $25.2M | Put options by funds: $9.11M
17% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 87
2% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 51
2% less funds holding
Funds holding: 300 → 295 (-5)
3.06% less ownership
Funds ownership: 96.95% → 93.89% (-3.1%)
19% less capital invested
Capital invested by funds: $3.95B → $3.21B (-$739M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$89.7M |
| 2 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$52.7M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$26.8M |
| 4 |
Bank of New York Mellon
New York
|
+$24.2M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$21.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$93.3M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$57.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$51.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$20.4M |
GH Hedge Fund Activity: Q3 2023 in Review
295 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2023, worth a combined $3.21B — down 19% from $3.95B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of GH and 50 opened new positions — a net loss of 1 holder — while 87 trimmed existing stakes and 102 added.
The largest buyer was Deep Track Capital, adding an estimated $89.7M. The largest seller was Point72 Asset Management, cutting an estimated $93.3M.
- 295 institutional investors held Guardant Health (GH) as of Q3 2023, down from 300 in Q2 2023.
- Funds reported $3.21B of Guardant Health stock for Q3 2023, down 19% quarter-over-quarter.
- 50 funds opened new Guardant Health positions in Q3 2023 and 51 closed out, a net change of -1 holder.
- The largest Guardant Health buyer in Q3 2023 was Deep Track Capital, an estimated $89.7M added.
- The largest Guardant Health seller in Q3 2023 was Point72 Asset Management, an estimated $93.3M sold.
Based on aggregated 13F filings for Q3 2023.